The estimated Net Worth of Sandra Leung is at least $41.4 Million dollars as of 10 March 2024. Ms. Leung owns over 46,784 units of Bristol-Myers Squibb Co stock worth over $18,042,050 and over the last 16 years she sold BMY stock worth over $15,810,946. In addition, she makes $7,516,460 as Executive Vice President and General Counsel at Bristol-Myers Squibb Co.
Sandra has made over 37 trades of the Bristol-Myers Squibb Co stock since 2010, according to the Form 4 filled with the SEC. Most recently she exercised 46,784 units of BMY stock worth $2,273,235 on 10 March 2024.
The largest trade she's ever made was exercising 169,893 units of Bristol-Myers Squibb Co stock on 28 February 2019 worth over $2,974,826. On average, Sandra trades about 38,297 units every 107 days since 2008. As of 10 March 2024 she still owns at least 371,312 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Ms. Leung stock trades at the bottom of the page.
Sandra Leung serves as Executive Vice President, General Counsel of the Company. From 2007 to 2014 – General Counsel and Corporate Secretary 2014 to 2015 – Executive Vice President, General Counsel and Corporate Secretary 2015 to present – Executive Vice President, General Counsel.
As the Executive Vice President and General Counsel of Bristol-Myers Squibb Co, the total compensation of Sandra Leung at Bristol-Myers Squibb Co is $7,516,460. There are 1 executives at Bristol-Myers Squibb Co getting paid more, with Giovanni Caforio having the highest compensation of $18,767,300.
Sandra Leung is 59, she's been the Executive Vice President and General Counsel of Bristol-Myers Squibb Co since 2015. There are 12 older and 23 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
Sandra's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543.
Over the last 16 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, and Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: